ArticleOncoTargets and therapy2026

Survival Outcomes and Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated First-Line mFOLFOXIRI Plus Bevacizumab: A Real-World Study in Vietnam.

Ngan Thi Kim Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.